JP7206216B2 - 酒さを処置するためのポンガミア油と４－ｔ－ブチルシクロヘキサノールの組合せを含んでなる化粧用組成物 - Google Patents

酒さを処置するためのポンガミア油と４－ｔ－ブチルシクロヘキサノールの組合せを含んでなる化粧用組成物 Download PDF

Info

Publication number
JP7206216B2
JP7206216B2 JP2019556733A JP2019556733A JP7206216B2 JP 7206216 B2 JP7206216 B2 JP 7206216B2 JP 2019556733 A JP2019556733 A JP 2019556733A JP 2019556733 A JP2019556733 A JP 2019556733A JP 7206216 B2 JP7206216 B2 JP 7206216B2
Authority
JP
Japan
Prior art keywords
rosacea
butylcyclohexanol
oil
combination
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019556733A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020504178A (ja
JP2020504178A5 (https=
Inventor
エレーヌ、エルナンデス－ピジョン
ナタリー、カステス－リッツィ
ステファヌ、ポワニー
マリー、フランソワーズ、アリー
イブ、ブリュネル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Dermo Cosmetique SA
Original Assignee
Pierre Fabre Dermo Cosmetique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Dermo Cosmetique SA filed Critical Pierre Fabre Dermo Cosmetique SA
Publication of JP2020504178A publication Critical patent/JP2020504178A/ja
Publication of JP2020504178A5 publication Critical patent/JP2020504178A5/ja
Application granted granted Critical
Publication of JP7206216B2 publication Critical patent/JP7206216B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/486—Millettia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2019556733A 2017-01-04 2017-12-22 酒さを処置するためのポンガミア油と４－ｔ－ブチルシクロヘキサノールの組合せを含んでなる化粧用組成物 Active JP7206216B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1750059A FR3061434B1 (fr) 2017-01-04 2017-01-04 Composition cosmetique comprenant une association d'huile de pongamia et de pentylene glycol 4-t-butylcyclohexanol pour lutter contre la rosacee
FR1750059 2017-01-04
PCT/EP2017/084456 WO2018127435A1 (fr) 2017-01-04 2017-12-22 Composition cosmétique comprenant une association d'huile de pongamia et du 4-t-butylcyclohexanol pour lutter contre la rosacée

Publications (3)

Publication Number Publication Date
JP2020504178A JP2020504178A (ja) 2020-02-06
JP2020504178A5 JP2020504178A5 (https=) 2021-01-21
JP7206216B2 true JP7206216B2 (ja) 2023-01-17

Family

ID=58669934

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019556733A Active JP7206216B2 (ja) 2017-01-04 2017-12-22 酒さを処置するためのポンガミア油と４－ｔ－ブチルシクロヘキサノールの組合せを含んでなる化粧用組成物

Country Status (8)

Country Link
US (1) US10765641B2 (https=)
EP (1) EP3565569A1 (https=)
JP (1) JP7206216B2 (https=)
KR (1) KR102585914B1 (https=)
CN (1) CN110392576B (https=)
BR (1) BR112019013824B8 (https=)
FR (1) FR3061434B1 (https=)
WO (1) WO2018127435A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3105731B1 (fr) 2019-12-31 2023-06-30 Cosmact Composition cosmétique et/ou dermatologique comprenant une association de glycyrrhétinate de stéaryle, de férulate d’éthyle et d’une huile végétale
CN112773738A (zh) * 2021-02-23 2021-05-11 上海美浮特生物科技有限公司 一种保湿舒缓组合物，其制备方法、护肤品及应用
CN115925666B (zh) * 2022-11-24 2023-07-14 上海克琴科技有限公司 一种小分子化合物及其用途和制备方法
CN116983231B (zh) * 2023-08-21 2024-12-27 广州君奕科技有限公司 一种生物型防晒、修护屏障添加剂组合物、制备方法、应用和防晒数值的测试方法
WO2025081335A1 (en) * 2023-10-17 2025-04-24 Beiersdorf Ag Cosmetic product comprising 4-t-butylcyclohexanol, polyglyceryl ester and an oil
WO2025081339A1 (en) * 2023-10-17 2025-04-24 Beiersdorf Ag Cosmetic product comprising 4-t-butylcyclohexanol, monoglyceryl ester and an oil
CN121243130A (zh) * 2025-09-18 2026-01-02 中国人民解放军总医院第三医学中心 西柏三烯二醇在制备预防和治疗玫瑰痤疮的药物中的应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110206789A1 (en) 2008-04-10 2011-08-25 Prime Interaction Holdings Limited HERBAL EXTRACT PRODUCTS AND METHODS (as amended)
JP2012523381A (ja) 2009-04-09 2012-10-04 シムライズ アーゲー 皮膚刺激低下剤としてトランス−ｔｅｒｔ−ブチルシクロヘキサノールを含む組成物
US20150148393A1 (en) 2012-06-04 2015-05-28 General Topics S.R.L. Cosmetic and/or pharmaceutical composition for the treatment of skin inflammation and related syndromes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142037A0 (en) 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
US20110165136A1 (en) * 2010-01-01 2011-07-07 Himalaya Global Holdings Ltd. Novel Herbal Composition for Treatment of Psoriasis and Other Skin Disorders
EP2667854B1 (en) * 2011-01-24 2019-01-16 Anterios, Inc. Nanoparticle compositions
CN103796652A (zh) * 2011-07-14 2014-05-14 阿勒根公司 羟甲唑啉的凝胶组合物及使用方法
UA109359C2 (xx) * 2011-11-10 2015-08-10 Лікування захворювань і станів шкіри 7-(1h-імідазол-4-ілметил)-5,6,7,8-тетрагідрохіноліном

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110206789A1 (en) 2008-04-10 2011-08-25 Prime Interaction Holdings Limited HERBAL EXTRACT PRODUCTS AND METHODS (as amended)
JP2012523381A (ja) 2009-04-09 2012-10-04 シムライズ アーゲー 皮膚刺激低下剤としてトランス−ｔｅｒｔ−ブチルシクロヘキサノールを含む組成物
US20150148393A1 (en) 2012-06-04 2015-05-28 General Topics S.R.L. Cosmetic and/or pharmaceutical composition for the treatment of skin inflammation and related syndromes

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS，ROSACEA THERAPY LOTION，[ONLINE]，2016年09月15日，P1，http://web.archive.org/web/20160915063559/http://www.pratimaskincare.com/rosacea-therapy-lotion
EXPERIMENTAL DERMATOLOGY，2010年11月，VOL:19, NR:11,，PAGE(S):980-986
J.Am.Acad.Dermatol.，2013年，Vol.69，S15-26
Research Journal of Pharmceutical, Biological, and Chemical Sciences，2014年，Vol.5，pp.546-551

Also Published As

Publication number Publication date
CN110392576A (zh) 2019-10-29
FR3061434B1 (fr) 2019-07-12
KR102585914B1 (ko) 2023-10-06
BR112019013824A2 (pt) 2020-01-28
JP2020504178A (ja) 2020-02-06
FR3061434A1 (fr) 2018-07-06
US20190350875A1 (en) 2019-11-21
WO2018127435A1 (fr) 2018-07-12
KR20190103255A (ko) 2019-09-04
BR112019013824B8 (pt) 2023-01-24
CN110392576B (zh) 2021-11-05
EP3565569A1 (fr) 2019-11-13
BR112019013824B1 (pt) 2022-11-08
US10765641B2 (en) 2020-09-08

Similar Documents

Publication Publication Date Title
JP7206216B2 (ja) 酒さを処置するためのポンガミア油と４－ｔ－ブチルシクロヘキサノールの組合せを含んでなる化粧用組成物
KR102443662B1 (ko) 피부에서 미용적 또는 치료적 사용을 위한 색시프라가 추출물
KR102343166B1 (ko) 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드를 함유한 항산화, 항염, 피부진정, 재생, 탄력 및 보습 효과를 갖는 화장료 조성물
US8986755B1 (en) Skin moisturizer
US20040101577A1 (en) Composition for treating acne vulgaris and fabrication method
KR101587446B1 (ko) 아임계추출조건으로 추출한 추출물 il-s를 포함하는 항균, 보습, 가려움개선, 세라마이드증가, 항염 효과를 지닌 화장료 조성물
KR20240105664A (ko) 동백나무 과피 추출물 및 백미꽃 추출물을 유효성분으로 포함하는 두피 진정용 화장료 조성물
KR101574248B1 (ko) 왕호장 추출물을 유효성분으로 함유하는 피부 주름개선용 화장료 조성물
KR20170058546A (ko) 주름개선용 화장료 조성물
KR20220012211A (ko) 코르크참나무 추출물을 포함하는 여드름 피부 개선용 화장료 조성물
KR20130090071A (ko) 초임계유체를 이용한 생강으로부터 여드름성 피부 항균성분의 선택추출법
CN109364290A (zh) 一种薰衣草精油脂质体液体创可贴及其制备方法
KR102316415B1 (ko) 남천을 이용한 화장료 조성물의 제조방법
KR101252560B1 (ko) 봉숭아 추출물을 함유하는 여드름 개선용 화장료 조성물
JP2024517225A (ja) 皮膚症状を治療するためのマヌカオイルおよびパルマローザオイルを含有する局所用組成物
KR101033814B1 (ko) 비누풀 추출물을 함유하는 블랙헤드 제거용 화장료 조성물
HK40016596B (en) Cosmetic composition comprising a combination of pongamia oil and 4-t-butylcyclohexanol for the treatment of rosacea
HK40016596A (en) Cosmetic composition comprising a combination of pongamia oil and 4-t-butylcyclohexanol for the treatment of rosacea
US8986752B1 (en) Skin care treatment
KR102316407B1 (ko) 남천을 이용한 화장료 조성물
Ali et al. A Review on different formulations of Punica granatum
Reddy et al. IN VIVO STUDY (WOUND HEALING ACTIVITY) OF THE EXTRACT FROM THE FRUITS OF ANANAS COMOSUS
BR102017010480A2 (pt) composição cosmética compreendendo manteiga de planta do gênero platonia, processo de preparação da referida composição, uso da mesma e método cosmético
KR20250137274A (ko) 향상된 피부 침투성을 갖는 팜오일을 함유하는 기초 화장용 조성물 및 그 제조 방법
KR20210005203A (ko) 장미증 및 피부 발진을 조절하기 위한 테오브로마 카카오 원두의 외피 추출물

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190904

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201204

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201204

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20210930

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211012

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220111

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220628

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221028

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20221028

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20221108

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20221111

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20221209

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230104

R150 Certificate of patent or registration of utility model

Ref document number: 7206216

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250